Implementing COVID-19 Testing in Massachusetts Phased Reopening Plans

August 12, 2020 12:00 PM - 1:00 PM

Webinar, click "live-stream" button to view

Add to Calendar 8/12/2020 12:00:00 PM 8/12/2020 1:00:00 PM Implementing COVID-19 Testing in Massachusetts Phased Reopening Plans

COVID-19 testing is a significant part of the answer to reopen our economy and our lives – and will remain crucial even after vaccines or therapies eventually become available. Municipalities, companies, universities, hospitals, school systems, and families want to know how and when they could implement testing or be tested so our society can reopen more fully and more confidently. Ideally, we want a highly reliable, rapid test that provides results in minutes. We hear it is taking 7+ days to get a test back due to the current surges in our country and it seems like test companies are way over capacity. How does the MassBio community implement testing? Is it even realistic now? What kind of testing should be implemented? We’ll hear from those who were on the forefront of implementing testing as part of their reopening strategy and get a pulse on how it is going. We’ll also address the shortfalls of current testing and offer strategies to undertake testing as a key component of your reopening plans.

Webinar link will be emailed to participants the day before - you can also access it from the "Live Stream" tab below. This event is for members-only. 

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

Webinar, click "live-stream" button to view

COVID-19 testing is a significant part of the answer to reopen our economy and our lives – and will remain crucial even after vaccines or therapies eventually become available. Municipalities, companies, universities, hospitals, school systems, and families want to know how and when they could implement testing or be tested so our society can reopen more fully and more confidently. Ideally, we want a highly reliable, rapid test that provides results in minutes. We hear it is taking 7+ days to get a test back due to the current surges in our country and it seems like test companies are way over capacity. How does the MassBio community implement testing? Is it even realistic now? What kind of testing should be implemented? We’ll hear from those who were on the forefront of implementing testing as part of their reopening strategy and get a pulse on how it is going. We’ll also address the shortfalls of current testing and offer strategies to undertake testing as a key component of your reopening plans.

Webinar link will be emailed to participants the day before - you can also access it from the "Live Stream" tab below. This event is for members-only. 

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

Head of HCLS Strategy at KPMG, and the global healthcare and life sciences deal advisory leader
Kristin is the head of HCLS strategy at KPMG, and the global healthcare and life sciences deal advisory leader. She has 25 years of experience in research and strategy consulting and M&A diligence in medical innovation and the healthcare and life sciences industry. Her primary areas of focus are deal advisory and corporate strategy for pharmaceutical, diagnostics, and consumer health companies, investors, and medical institutions worldwide. She is a noted speaker, workshop leader, and writer in the life sciences industry. She is also a leader in clinical laboratory and medical innovation, developing product and service strategies, operations, and global deals with on-the-ground experience in North America, Latin America, Europe, Asia, India, the Middle East, and the Caribbean. Her book, Personalizing Precision Medicine, was a clinical best seller and has garnered attention worldwide for its all-inclusive and comprehensive look at global precision medicine. Kristin also works with health systems and affiliated organizations on their innovative services strategies, diligences, and operations, including clinical laboratory builds, health IT, hospital services, and clinical outreach strategy. Kristin is on our KPMG Restart America task force and develops COVID-19 diagnostic and other service programs for large employers, institutions, and regions seeking recovery.